Hard To Financials
Based on the analysis of Hard To's profitability, liquidity, and operating efficiency, Hard to Treat is performing exceptionally good at this time. It has a great odds to report excellent financial results in January. At this time, Hard To's Total Stockholder Equity is comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 2.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 2 M in 2024. Key indicators impacting Hard To's financial strength include:
Operating Margin 0.1727 | Profit Margin 0.1582 |
The financial analysis of Hard To is a critical element in measuring its lifeblood. Investors should not minimize Hard To's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Hard | Select Account or Indicator |
Understanding current and past Hard To Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hard To's financial statements are interrelated, with each one affecting the others. For example, an increase in Hard To's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Hard To's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hard to Treat. Check Hard To's Beneish M Score to see the likelihood of Hard To's management manipulating its earnings.
Hard To Stock Summary
Hard To competes with Fate Therapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, and Heron Therapeuti. Hard to Treat Diseases Inc. manufactures, supplies, and exports biopharmaceuticals and vaccines in China and internationally. Hard to Treat Diseases Inc. was founded in 2009 and is based in Shenzhen, China. Hard To operates under Biotechnology classification in the United States and is traded on OTC Exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| Business Address | Room EF, 12F, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.mellowhope.com |
| Phone | 86 755 8272 0498 |
| Currency | USD - US Dollar |
Hard To Key Financial Ratios
| Revenue | 5.39 M | ||||
| Gross Profit | 1.42 M | ||||
| Net Income | 621.6 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M |
Hard Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hard To's current stock value. Our valuation model uses many indicators to compare Hard To value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hard To competition to find correlations between indicators driving Hard To's intrinsic value. More Info.Hard to Treat is rated # 2 in profit margin category among its peers. It is one of the top stocks in operating margin category among its peers reporting about 1.09 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all technique that is used if you cannot value Hard To by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Hard to Treat Systematic Risk
Hard To's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hard To volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Hard to Treat correlated with the market. If Beta is less than 0 Hard To generally moves in the opposite direction as compared to the market. If Hard To Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hard to Treat is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hard To is generally in the same direction as the market. If Beta > 1 Hard To moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Hard To is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Hard has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Hard To's financials are consistent with your investment objective using the following steps:- Review Hard To's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Hard To's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Hard To's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Hard To's stock is overvalued or undervalued.
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.